Sharechat Logo

FPH - Notification of closing date for Director nominations

Monday 12th June 2023

Text too small?

Auckland, New Zealand, 12 June 2023 - Fisher & Paykel Healthcare Corporation Limited advises that its 2023 Annual Shareholders’ Meeting will be held online at www.virtualmeeting.co.nz/FPH23 and in person at our East Tāmaki campus in the Daniell Building, 15 Maurice Paykel Place, East Tāmaki, Auckland, New Zealand on Tuesday, 29 August 2023 commencing at 2.00pm (NZST).

 

In respect of its 2023 ASM, Fisher & Paykel Healthcare Corporation Limited advises that the closing date for director nominations is 30 June 2023.

 

Nominations should be addressed by mail or email to:

 

Raelene Leonard

General Counsel & Company Secretary

Fisher & Paykel Healthcare Corporation Limited

PO Box 14348

Panmure, Auckland 1741

New Zealand

 

Email: raelene.leonard@fphcare.co.nz

 

Notice of the ASM will be released to the NZX and ASX, along with instructions for attending the virtual meeting, at least 20 working days prior to the meeting.

 

For more information about the company visit our website www.fphcare.com.

 

Media & Investor Contacts:

Dan Adolph

Senior Communications and Investor Relations Manager

daniel.adolph@fphcare.co.nz

+64 22 511 4050

 

Hayden Brown

Head of Capital Markets and Investor Relations

hayden.brown@fphcare.co.nz

+64 27 807 8073

 

Authorised by Raelene Leonard, General Counsel & Company Secretary.



  General Finance Advertising    

Comments from our readers

No comments yet

Add your comment:
Your name:
Your email:
Not displayed to the public
Comment:
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Related News:

FBU - Fletcher Building Announces Director Appointment
December 23rd Morning Report
MWE - Suspension of Trading and Delisting
EBOS welcomes finalisation of First PWA
CVT - AMENDED: Bank covenant waiver and trading update
Gentrack Annual Report 2024
December 20th Morning Report
Rua Bioscience announces launch of new products in the UK
TEM - Appointment to the Board of Directors
December 19th Morning Report